Conference Coverage

FDA Set to Evaluate New Vaccine Technology

Published in Gene Therapy Weekly, April 10th, 1995

The U.S. Food and Drug Administration (FDA) is prepared to evaluate new preventive and therapeutic vaccines based on emerging technologies, according to Karen Goldenthal, director of vaccines and related product applications for the FDA's Center for Biologicals Evaluation and Research (CBER).

In an address to the Third Annual Vaccines: New Technologies and Applications Conference, held March 20-22 in Alexandria, Virginia, Goldenthal noted that current areas of vaccine development include new combination vaccines, less reactogenic vaccines, novel adjuvants, polysaccharide conjugate vaccines, and new clinical indications for existing vaccines.

New...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-04-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry